NCT03337932
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +12 more
- Locations
-
- University Medical center Ljubljana Ljubljana, Slovenia
Clinical trial condition
Erythema
Explore clinical trials studying Erythema. Study availability and eligibility vary by location and protocol.
39 public trials
7 recruiting studies
Erythema trial results
NCT07338279
- Conditions
- DNA Virus Infections, Erythema, Erythema Infectiosum, +9 more
- Locations
-
- Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
- ASST degli Spedali Civili di Brescia Brescia, Italy
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy
- ASST Fatebenefratelli Sacco Milan, Italy
NCT06451913
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +18 more
- Locations
-
- University Medical Centre Ljubljana Ljubljana, Slovenia
NCT04711200
- Conditions
- Adipose Derived Stromal Cells, Chemically-Induced Disorders, Dermatitis, +20 more
- Locations
-
- Henri Mondor Créteil, France
Recruiting
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
NCT06704698
- Conditions
- Behavior, Cold, Common Cold, +27 more
- Locations
-
- Jiangling Wang Hangzhou, Zhejiang, China
NCT06119490
- Conditions
- Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +15 more
- Locations
-
- Department of Dermatology, the First Affiliated Hospital of Fujian Medical University. Fuzhou, Fujian, China
NCT03659227
- Conditions
- AGEP, Bullous Dermatosis Caused by Drug Treatment (Disorder), Chemically-Induced Disorders, +24 more
- Locations
-
- Henri Mondor Créteil, France
Not Yet Recruiting
Subconjunctival Humira for Boston Keratoprosthesis
NCT06926478
- Conditions
- Chemically-Induced Disorders, Conjunctival Diseases, Dermatitis, +20 more
- Locations
-
- Massachusetts Eye and Ear Boston, Massachusetts, United States
Not Yet Recruiting
HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness
NCT07369622
- Conditions
- Arthritis, Arthritis, Gouty, Chemically-Induced Disorders, +33 more
- Locations
-
Not specified
Not Yet Recruiting
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.
NCT07110662
- Conditions
- Chemically-Induced Disorders, Cutaneous Adverse Drug Reactions (CADR), Dermatitis, +17 more
- Locations
-
- Reference Center for Toxic, Toxin and Toxidermal Bullous Dermatoses - E. Herriot Hospital Lyon, France